Hospital
Elmhurst Memorial Hospital
Elmhurst Memorial Hospital was paid $1.87M by Medicaid between Jan 2018 and Jun 2020, across 119 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 56% of everything it billed.
33Billing provider infoELMHURST MEMORIAL HOSPITAL
ELMHURST, IL 60126
ELMHURST, IL 60126
33aNPI1548306343assigned 01/29/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.87M
24GClaims100,070
24DCodes billed119
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#28 of 129
Median peer was paid$547K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,741 | $523K | |
| 2019 | 41,920 | $901K | |
| 2020 | 28,409 | $448K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 56% | 10,573 | 2,401 | $1.05M |
| 97162 | 3.7% | 693 | 452 | $70K | |
| 97161 | 3.2% | 602 | 418 | $61K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.1% | 1,064 | 805 | $59K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 2,716 | 2,297 | $50K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 2,693 | 2,280 | $50K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.1% | 1,823 | 1,504 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 4,560 | 3,815 | $30K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 2,585 | 1,851 | $27K |
| 80053 | Comprehensive metabolic panel | 1.4% | 5,986 | 4,938 | $26K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.4% | 315 | 157 | $25K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 1,637 | 536 | $25K |
107 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.3% | 334 | $24K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.2% | 1,707 | $22K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,071 | $18K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 114 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,812 | $16K |
| 87631 | <1% | 383 | $14K | |
| 86780 | <1% | 1,831 | $13K | |
| 87430 | <1% | 2,205 | $11K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 767 | $11K |
| 80061 | Lipid panel | <1% | 4,158 | $10K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 745 | $10K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 294 | $9K |
| 87653 | <1% | 439 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,135 | $9K |
| 87808 | <1% | 1,161 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 179 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,113 | $7K |
| 87081 | <1% | 2,855 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 751 | $6K |
| 87340 | <1% | 1,213 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,656 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,479 | $6K |
| 86803 | <1% | 862 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 491 | $6K |
| 82607 | <1% | 947 | $5K | |
| 84439 | <1% | 1,289 | $5K | |
| 85027 | <1% | 1,901 | $5K | |
| 83655 | <1% | 570 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,305 | $4K |
| 73630 | <1% | 422 | $4K | |
| 97163 | <1% | 41 | $4K | |
| 72110 | <1% | 220 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 252 | $4K |
| 86480 | <1% | 147 | $3K | |
| 73610 | <1% | 235 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 147 | $3K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 368 | $3K |
| 87186 | <1% | 503 | $3K | |
| 87205 | <1% | 1,368 | $2K | |
| 73130 | <1% | 261 | $2K | |
| 84466 | <1% | 565 | $2K | |
| 87581 | <1% | 114 | $2K | |
| 87486 | <1% | 114 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 21 | $2K |
| 86038 | <1% | 281 | $2K | |
| 81001 | <1% | 1,615 | $2K | |
| 82728 | <1% | 542 | $2K | |
| 73030 | <1% | 159 | $2K | |
| 86850 | <1% | 819 | $2K | |
| 82570 | <1% | 864 | $2K | |
| 83540 | <1% | 578 | $2K | |
| 73110 | <1% | 151 | $2K | |
| 86140 | <1% | 727 | $2K | |
| 86762 | <1% | 589 | $2K | |
| 86901 | <1% | 827 | $1K | |
| 82043 | <1% | 781 | $1K | |
| 73560 | <1% | 131 | $1K | |
| 82950 | <1% | 605 | $1K | |
| 85652 | <1% | 955 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 40 | $1K |
| 86900 | <1% | 832 | $992.19 | |
| 84450 | <1% | 435 | $911.56 | |
| 86003 | <1% | 97 | $873.15 | |
| 81003 | <1% | 963 | $790.16 | |
| 73564 | <1% | 76 | $775.22 | |
| 85610 | <1% | 474 | $742.52 | |
| 84460 | <1% | 346 | $733.35 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 16 | $700.03 |
| 82746 | <1% | 121 | $616.95 | |
| 84481 | <1% | 127 | $609.76 | |
| 84403 | <1% | 31 | $578.78 | |
| 84702 | <1% | 172 | $576.96 | |
| 86431 | <1% | 154 | $504.85 | |
| 80076 | <1% | 145 | $478.94 | |
| 86706 | <1% | 73 | $477.68 | |
| 82951 | <1% | 85 | $467.41 | |
| 73140 | <1% | 56 | $386.66 | |
| 87088 | <1% | 77 | $380.31 | |
| 83516 | <1% | 41 | $355.50 | |
| 73562 | <1% | 35 | $353.88 | |
| 83735 | <1% | 114 | $352.08 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 36 | $347.18 |
| 85018 | <1% | 285 | $295.07 | |
| 82784 | <1% | 43 | $283.96 | |
| 84703 | <1% | 86 | $283.83 | |
| 81025 | <1% | 339 | $275.92 | |
| 81002 | <1% | 245 | $259.44 | |
| 85014 | <1% | 231 | $241.75 | |
| 83001 | <1% | 29 | $238.69 | |
| 73502 | <1% | 17 | $181.28 | |
| 87147 | <1% | 107 | $157.56 | |
| 74018 | <1% | 14 | $142.39 | |
| 82565 | <1% | 59 | $141.27 | |
| 84153 | <1% | 21 | $135.55 | |
| 86200 | <1% | 26 | $132.35 | |
| 86704 | <1% | 18 | $122.24 | |
| 84165 | <1% | 16 | $76.65 | |
| 80050 | General health panel | <1% | 42 | $74.55 |
| 82785 | <1% | 29 | $73.89 | |
| 86787 | <1% | 15 | $58.40 | |
| 82952 | <1% | 30 | $50.22 | |
| 85730 | <1% | 12 | $31.62 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 46 | $28.34 |
| 81015 | <1% | 15 | $16.51 | |
| 84156 | <1% | 14 | $14.56 | |
| 87077 | 0% | 56 | $0.00 | |
| 87106 | 0% | 313 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALDER, SHAUN (VP, HOSPITAL PFS)
| Provider | Location | Paid |
|---|---|---|
| Edward Hospital | Naperville, IL | $2.16M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.